RV/LV Analysis

Imbio

RV/LV ratio can inform a physician on the severity of a Pulmonary Embolism by comparing the diameters of the right and left ventricles of the heart.
Product specifications Information source: Vendor
Last updated: March 16, 2021
General
Product name RV/LV Analysis
Company Imbio
Subspeciality Cardiac, Chest
Modality CT
Disease targeted Pulmonary Embolism
Key-features ventricle diameter quantification, RV/LV ratio
Suggested use Before: stratifying reading process (non, single, double read), adapting worklist order, flagging acute findings
During: perception aid (prompting all abnormalities/results/heatmaps), interactive decision support (shows abnormalities/results only on demand), report suggestion
Without interference of a radiologist: AI-only diagnosis
Data characteristics
Population
Input Contrast CT
Input format DICOM
Output Quantitative report
Output format PDF and DICOM
Technology
Integration Integration in standard reading environment (PACS), Integration via AI marketplace or distribution platform, Stand-alone third party application, Stand-alone webbased
Deployment Locally virtualized (virtual machine, docker), Cloud-based
Trigger for analysis Automatically, right after the image acquisition, On demand, triggered by a user through e.g. a button click, image upload, etc.
Processing time 1 - 10 minutes
Certification
CE
No or not yet,
FDA
510(k) cleared, Class II
Market presence
On market since 03-2021
Distribution channels
Countries present (clinical, non-research use) <5
Paying clinical customers (institutes)
Research/test users (institutes) >5
Pricing
Pricing model Pay-per-use, Subscription
Based on Number of installations, Number of analyses
Evidence
Peer reviewed papers on performance
Non-peer reviewed papers on performance
Other relevant papers